Literature DB >> 21136135

The plasmin-antiplasmin system: structural and functional aspects.

Johann Schaller1, Simon S Gerber.   

Abstract

The plasmin-antiplasmin system plays a key role in blood coagulation and fibrinolysis. Plasmin and α(2)-antiplasmin are primarily responsible for a controlled and regulated dissolution of the fibrin polymers into soluble fragments. However, besides plasmin(ogen) and α(2)-antiplasmin the system contains a series of specific activators and inhibitors. The main physiological activators of plasminogen are tissue-type plasminogen activator, which is mainly involved in the dissolution of the fibrin polymers by plasmin, and urokinase-type plasminogen activator, which is primarily responsible for the generation of plasmin activity in the intercellular space. Both activators are multidomain serine proteases. Besides the main physiological inhibitor α(2)-antiplasmin, the plasmin-antiplasmin system is also regulated by the general protease inhibitor α(2)-macroglobulin, a member of the protease inhibitor I39 family. The activity of the plasminogen activators is primarily regulated by the plasminogen activator inhibitors 1 and 2, members of the serine protease inhibitor superfamily.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21136135     DOI: 10.1007/s00018-010-0566-5

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  181 in total

1.  On the kinetics of the reaction between human antiplasmin and plasmin.

Authors:  B Wiman; D Collen
Journal:  Eur J Biochem       Date:  1978-03-15

2.  Proton magnetic resonance study of lysine-binding to the kringle 4 domain of human plasminogen. The structure of the binding site.

Authors:  V Ramesh; A M Petros; M Llinás; A Tulinsky; C H Park
Journal:  J Mol Biol       Date:  1987-12-05       Impact factor: 5.469

3.  The N- and O-linked carbohydrate chains of human, bovine and porcine plasminogen. Species specificity in relation to sialylation and fucosylation patterns.

Authors:  T Marti; J Schaller; E E Rickli; K Schmid; J P Kamerling; G J Gerwig; H van Halbeek; J F Vliegenthart
Journal:  Eur J Biochem       Date:  1988-04-05

4.  Neuroserpin, an axonally secreted serine protease inhibitor.

Authors:  T Osterwalder; J Contartese; E T Stoeckli; T B Kuhn; P Sonderegger
Journal:  EMBO J       Date:  1996-06-17       Impact factor: 11.598

5.  Solution structure of the kringle domain from urokinase-type plasminogen activator.

Authors:  X Li; A M Bokman; M Llinás; R A Smith; C M Dobson
Journal:  J Mol Biol       Date:  1994-02-04       Impact factor: 5.469

6.  High resolution analysis of functional determinants on human tissue-type plasminogen activator.

Authors:  W F Bennett; N F Paoni; B A Keyt; D Botstein; A J Jones; L Presta; F M Wurm; M J Zoller
Journal:  J Biol Chem       Date:  1991-03-15       Impact factor: 5.157

7.  Antibodies to plasminogen activator inhibit human tumor metastasis.

Authors:  L Ossowski; E Reich
Journal:  Cell       Date:  1983-12       Impact factor: 41.582

8.  Structure of the human alpha-2 macroglobulin gene and its promotor.

Authors:  G Matthijs; K Devriendt; J J Cassiman; H Van den Berghe; P Marynen
Journal:  Biochem Biophys Res Commun       Date:  1992-04-30       Impact factor: 3.575

9.  Isolation and characterization of the human tissue-type plasminogen activator structural gene including its 5' flanking region.

Authors:  R Fisher; E K Waller; G Grossi; D Thompson; R Tizard; W D Schleuning
Journal:  J Biol Chem       Date:  1985-09-15       Impact factor: 5.157

10.  A unique interhelical insertion in plasminogen activator inhibitor-2 contains three glutamines, Gln83, Gln84, Gln86, essential for transglutaminase-mediated cross-linking.

Authors:  P H Jensen; E Schüler; G Woodrow; M Richardson; N Goss; P Højrup; T E Petersen; L K Rasmussen
Journal:  J Biol Chem       Date:  1994-05-27       Impact factor: 5.157

View more
  44 in total

1.  Coagulation factor XIIIa is inactivated by plasmin.

Authors:  Woosuk S Hur; Nima Mazinani; X J David Lu; Heidi M Britton; James R Byrnes; Alisa S Wolberg; Christian J Kastrup
Journal:  Blood       Date:  2015-09-10       Impact factor: 22.113

2.  Plasma is the physiologic buffer of tissue plasminogen activator-mediated fibrinolysis: rationale for plasma-first resuscitation after life-threatening hemorrhage.

Authors:  Hunter B Moore; Ernest E Moore; Eduardo Gonzalez; Gregory Wiener; Michael P Chapman; Monika Dzieciatkowska; Angela Sauaia; Anirban Banerjee; Kirk C Hansen; Christopher Silliman
Journal:  J Am Coll Surg       Date:  2015-03-31       Impact factor: 6.113

3.  Distinct Proteomic Signatures in 16 HDL (High-Density Lipoprotein) Subspecies.

Authors:  Jeremy D Furtado; Rain Yamamoto; John T Melchior; Allison B Andraski; Maria Gamez-Guerrero; Patrick Mulcahy; Zeling He; Tianxi Cai; W Sean Davidson; Frank M Sacks
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-12       Impact factor: 8.311

4.  Colonic Lesions, Cytokine Profiles, and Gut Microbiota in Plasminogen-Deficient Mice.

Authors:  Bill Vestergaard; Łukasz Krych; Leif R Lund; Bettina P Jørgensen; Lars Hansen; Henrik E Jensen; Dennis S Nielsen; Axel K Hansen
Journal:  Comp Med       Date:  2015-10       Impact factor: 0.982

5.  Proteolytic cleavage of extracellular α-synuclein by plasmin: implications for Parkinson disease.

Authors:  Kwang Soo Kim; Yu Ree Choi; Ji-Young Park; Jung-Ho Lee; Dong Kyu Kim; Seung-Jae Lee; Seung R Paik; Ilo Jou; Sang Myun Park
Journal:  J Biol Chem       Date:  2012-05-22       Impact factor: 5.157

6.  Protein-Defined Subspecies of HDLs (High-Density Lipoproteins) and Differential Risk of Coronary Heart Disease in 4 Prospective Studies.

Authors:  Frank M Sacks; Liang Liang; Jeremy D Furtado; Tianxi Cai; W Sean Davidson; Zeling He; Robyn L McClelland; Eric B Rimm; Majken K Jensen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-09-10       Impact factor: 8.311

7.  Fibrin(ogen)-independent role of plasminogen activators in acetaminophen-induced liver injury.

Authors:  Bradley P Sullivan; Karen M Kassel; Alice Jone; Matthew J Flick; James P Luyendyk
Journal:  Am J Pathol       Date:  2012-04-13       Impact factor: 4.307

8.  Plasmin and regulators of plasmin activity control the migratory capacity and adhesion of human T cells and dendritic cells by regulating cleavage of the chemokine CCL21.

Authors:  Natalie Lorenz; Evert Jan Loef; Inken D Kelch; Daniel J Verdon; Moyra M Black; Martin J Middleditch; David R Greenwood; E Scott Graham; Anna Es Brooks; P Rod Dunbar; Nigel P Birch
Journal:  Immunol Cell Biol       Date:  2016-06-15       Impact factor: 5.126

9.  Shock-induced systemic hyperfibrinolysis is attenuated by plasma-first resuscitation.

Authors:  Hunter B Moore; Ernest E Moore; Alexander P Morton; Eduardo Gonzalez; Miguel Fragoso; Michael P Chapman; Monika Dzieciatkowska; Kirk C Hansen; Anirban Banerjee; Angela Sauaia; Christopher C Silliman
Journal:  J Trauma Acute Care Surg       Date:  2015-12       Impact factor: 3.313

Review 10.  Proteolytic clearance of extracellular α-synuclein as a new therapeutic approach against Parkinson disease.

Authors:  Sang Myun Park; Kwang Soo Kim
Journal:  Prion       Date:  2012-11-15       Impact factor: 3.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.